Use of plasma rich in growth factors in patients with knee osteoarthritis

Abstract

The use of plasma rich in growth factors (PRGF) in patients with knee osteoarthritis is a promising therapeutic approach that aims to harness the regenerative potential of growth factors found in the patient's own blood. PRGF therapy involves the extraction and concentration of platelets and growth factors from the patient's blood, which are then injected into the affected knee joint. These growth factors are believed to stimulate tissue repair, reduce inflammation, and promote the regeneration of damaged cartilage in the joint. Research suggests that PRGF therapy may help improve pain, function, and quality of life in patients with knee osteoarthritis. By leveraging the natural healing properties of growth factors, PRGF therapy offers a minimally invasive treatment option that may provide symptomatic relief and potentially slow down the progression of osteoarthritis in the knee joint. Further studies are ongoing to better understand the efficacy and long-term benefits of PRGF therapy in the management of knee osteoarthritis.